Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Name: Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
License: Public Domain

Eli Lilly and Company

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300415
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.